Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are beneficial biomarkers of liver dysfunction, including nonalcoholic fatty liver (NAFL) and NASH, because high levels of ALT and AST are produced in the liver, unlike in other organs [72,73]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.